RUNX2 and cleidocranial dysplasia 1: To evaluate the modulation of FBXW11 in RUNX2 mutated cells, we first analysed the expression of FBXW11 in circulating MSCs (cMSCs) isolated from CCD paediatric patients and cultured in the absence or presence of osteogenic medium.